{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:02:04Z","timestamp":1791280924716,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012618","name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ophtha.2020.06.009","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T11:26:47Z","timestamp":1591961207000},"page":"1642-1651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3358-364X","authenticated-orcid":false,"given":"Panayiota","family":"Founti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0935-3713","authenticated-orcid":false,"given":"Catey","family":"Bunce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6802-8585","authenticated-orcid":false,"given":"Anthony P.","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4234-7083","authenticated-orcid":false,"given":"Jibran","family":"Mohamed-Noriega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Garway-Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9422","key":"10.1016\/j.ophtha.2020.06.009_bib1","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Primary open-angle glaucoma","volume":"363","author":"Weinreb","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ophtha.2020.06.009_bib2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ophtha.2007.08.037","article-title":"Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study","volume":"115","author":"McKean-Cowdin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.009_bib3","series-title":"Terminology and Guidelines for Glaucoma","year":"2014"},{"key":"10.1016\/j.ophtha.2020.06.009_bib5","series-title":"Glaucoma Guidelines","year":"2016"},{"issue":"Supp 11","key":"10.1016\/j.ophtha.2020.06.009_bib6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.survophthal.2008.08.006","article-title":"Risk factors for glaucoma onset and progression","volume":"53","author":"Coleman","year":"2008","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2020.06.009_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/IJG.0b013e31806540a1","article-title":"Risk factors and open-angle glaucoma: classification and application","volume":"16","author":"Boland","year":"2007","journal-title":"J\u00a0Glaucoma"},{"issue":"11","key":"10.1016\/j.ophtha.2020.06.009_bib8","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the early manifest glaucoma trial","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ophtha.2020.06.009_bib9","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","article-title":"Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study","volume":"111","author":"Nouri-Mahdavi","year":"2004","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2020.06.009_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","article-title":"Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors","volume":"116","author":"Musch","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2020.06.009_bib11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2020.06.009_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0002-9394(01)00964-3","article-title":"Risk factors for progression of visual field abnormalities in normal-tension glaucoma","volume":"131","author":"Drance","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2020.06.009_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ophtha.2012.07.028","article-title":"The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, placebo-controlled clinical trial: design and methodology","volume":"120","author":"Garway-Heath","year":"2013","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ophtha.2020.06.009_bib14","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.ophtha.2013.07.054","article-title":"The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics","volume":"120","author":"Lascaratos","year":"2013","journal-title":"Ophthalmology"},{"issue":"9975","key":"10.1016\/j.ophtha.2020.06.009_bib15","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ophtha.2020.06.009_bib16","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0161-6420(99)90497-9","article-title":"Early Manifest Glaucoma Trial: design and baseline data","volume":"106","author":"Leske","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.009_bib17","first-page":"CD003167","article-title":"Medical interventions for primary open angle glaucoma and ocular hypertension","volume":"4","author":"Vass","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ophtha.2020.06.009_bib18","first-page":"140","article-title":"Comparison of optic nerve imaging methods to distinguish normal eyes from those with glaucoma","volume":"43","author":"Greaney","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ophtha.2020.06.009_bib19","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1167\/iovs.12-9476","article-title":"Intervals between visual field tests when monitoring the glaucomatous patient: wait-and-see approach","volume":"53","author":"Crabb","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ophtha.2020.06.009_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1600-0420.1997.tb00392.x","article-title":"A\u00a0new generation of algorithms for computerized threshold perimetry, SITA","volume":"75","author":"Bengtsson","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"issue":"Suppl 1","key":"10.1016\/j.ophtha.2020.06.009_bib21","first-page":"9","article-title":"The International Classification of Headache Disorders: 2nd edition","volume":"24","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ophtha.2020.06.009_bib22","first-page":"645","article-title":"The diagnosis of ischaemic heart pain and intermittent claudication in field surveys","volume":"27","author":"Rose","year":"1962","journal-title":"Bull World Health Organ"},{"issue":"10","key":"10.1016\/j.ophtha.2020.06.009_bib23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0895-4356(92)90150-L","article-title":"The Edinburgh Claudication Questionnaire: an improved version of the WHO\/Rose Questionnaire for use in epidemiological surveys","volume":"45","author":"Leng","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.ophtha.2020.06.009_bib24","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1167\/iovs.03-0077","article-title":"Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project","volume":"44","author":"Le","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ophtha.2020.06.009_bib25","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ophtha.2010.01.034","article-title":"Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study","volume":"117","author":"Czudowska","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2020.06.009_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","article-title":"Risk factors for incident open-angle glaucoma: the Barbados Eye Studies","volume":"115","author":"Leske","year":"2008","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ophtha.2020.06.009_bib27","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.ophtha.2012.05.030","article-title":"Baseline risk factors that predict the development of open-angle glaucoma in a population: the Los Angeles Latino Eye Study","volume":"119","author":"Jiang","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2020.06.009_bib28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0039-6257(98)00002-2","article-title":"The association between cigarette smoking and ocular diseases","volume":"42","author":"Solberg","year":"1998","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2020.06.009_bib29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.annepidem.2008.04.002","article-title":"Smoking and the risk of age-related macular degeneration: a meta-analysis","volume":"18","author":"Cong","year":"2008","journal-title":"Ann Epidemiol"},{"issue":"7","key":"10.1016\/j.ophtha.2020.06.009_bib30","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1167\/iovs.12-9820","article-title":"Smoking and risk of age-related cataract: a meta-analysis","volume":"53","author":"Ye","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ophtha.2020.06.009_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/eje.0.1460153","article-title":"Smoking and thyroid disorders\u2014a meta-analysis","volume":"146","author":"Vestergaard","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ophtha.2020.06.009_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s001250051594","article-title":"UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis","volume":"44","author":"Stratton","year":"2001","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.ophtha.2020.06.009_bib33","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0161-6420(93)31429-6","article-title":"Relationship of drinking alcohol and smoking to prevalence of open-angle glaucoma. The Beaver Dam Eye Study","volume":"100","author":"Klein","year":"1993","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ophtha.2020.06.009_bib34","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/archopht.119.12.1819","article-title":"The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER","volume":"119","author":"Quigley","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2020.06.009_bib35","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ophtha.2007.05.032","article-title":"Sociodemographic, family history, and lifestyle risk factors for open-angle glaucoma and ocular hypertension. The Los Angeles Latino Eye Study","volume":"115","author":"Doshi","year":"2008","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2020.06.009_bib36","first-page":"A84","article-title":"Smoking and visual impairment among older adults with age-related eye diseases","volume":"8","author":"Zhang","year":"2011","journal-title":"Prev Chronic Dis"},{"issue":"6","key":"10.1016\/j.ophtha.2020.06.009_bib37","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/archophthalmol.2010.373","article-title":"Lifestyle and risk of developing open-angle glaucoma: the Rotterdam study","volume":"129","author":"Ramdas","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2020.06.009_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ajo.2011.01.032","article-title":"Risk factors for primary open-angle glaucoma and pseudoexfoliative glaucoma in the Thessaloniki eye study","volume":"152","author":"Topouzis","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2020.06.009_bib39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.annepidem.2011.03.006","article-title":"A\u00a0prospective study of diabetes, lifestyle factors, and glaucoma among African-American women","volume":"21","author":"Wise","year":"2011","journal-title":"Ann Epidemiol"},{"issue":"6","key":"10.1016\/j.ophtha.2020.06.009_bib40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1755-3768.2011.02356.x","article-title":"Nutritional, lifestyle and environmental factors in ocular hypertension and primary open-angle glaucoma: an exploratory case-control study","volume":"91","author":"Renard","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2020.06.009_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005761","article-title":"Smoking and incidence of glaucoma: The SUN Cohort","volume":"96","author":"P\u00e9rez-de-Arcelus","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.ophtha.2020.06.009_bib42","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/archopht.121.12.1762","article-title":"Prospective study of cigarette smoking and the risk of primary open-angle glaucoma","volume":"121","author":"Kang","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2020.06.009_bib43","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/eye.2017.292","article-title":"Cigarette smoking and glaucoma in the United States population","volume":"32","author":"Law","year":"2018","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.ophtha.2020.06.009_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/WNL.52.1.115","article-title":"Smoking and Parkinson\u2019s disease: a dose-response relationship","volume":"52","author":"Gorell","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ophtha.2020.06.009_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151841","article-title":"Association between Parkinson\u2019s disease and cigarette smoking, rural living, well-water consumption, farming and pesticide use: systematic review and meta-analysis","volume":"11","author":"Breckenridge","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ophtha.2020.06.009_bib46","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.10277","article-title":"A\u00a0meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson\u2019s disease","volume":"52","author":"Hern\u00e1n","year":"2002","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ophtha.2020.06.009_bib47","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0161-6420(99)90117-3","article-title":"Acute effects of cigarette smoking on tissue circulation in human optic nerve head and choroid-retina","volume":"106","author":"Tamaki","year":"1999","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2020.06.009_bib48","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1167\/iovs.13-12688","article-title":"A\u00a0nicotinic acetylcholine receptor agonist prevents loss of retinal ganglion cells in a glaucoma model","volume":"55","author":"Iwamoto","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ophtha.2020.06.009_bib49","first-page":"714","article-title":"The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch\u00a0Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2020.06.009_bib50","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.ophtha.2004.04.029","article-title":"Central corneal pachymetry and visual field progression in patients with open-angle glaucoma","volume":"111","author":"Kim","year":"2004","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ophtha.2020.06.009_bib51","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/bjo.2004.056622","article-title":"The influence of central corneal thickness and age on intraocular pressure measured by pneumotonometry, non-contact tonometry, the Tono-Pen XL, and Goldmann applanation tonometry","volume":"89","author":"Tonnu","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2020.06.009_bib52","first-page":"1389","article-title":"Effect of corneal thickness on intraocular pressure measurements with the pneumotonometer, Goldmann applanation tonometer, and Tono-Pen","volume":"43","author":"Bhan","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ophtha.2020.06.009_bib53","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcrs.2004.09.031","article-title":"Influence of corneal biomechanical properties on intraocular pressure measurement: quantitative analysis","volume":"31","author":"Liu","year":"2005","journal-title":"J\u00a0Cataract Refract Surg"},{"issue":"5","key":"10.1016\/j.ophtha.2020.06.009_bib54","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ajo.2005.12.007","article-title":"Central corneal thickness and corneal hysteresis associated with glaucoma damage","volume":"141","author":"Congdon","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2020.06.009_bib55","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ophtha.2013.01.032","article-title":"Corneal hysteresis as a risk factor for glaucoma progression: a prospective longitudinal study","volume":"120","author":"Medeiros","year":"2013","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ophtha.2020.06.009_bib56","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1167\/iovs.06-0557","article-title":"Corneal thickness- and age-related biomechanical properties of the cornea measured with the ocular response analyzer","volume":"47","author":"Kotecha","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642020305273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642020305273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:09:58Z","timestamp":1758982198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642020305273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0161642020305273"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2020.06.009","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2020.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}